Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Novozymes A/S (NVZMY : OTC)
 
 • Company Description   
Novozymes A/S is primarily engaged in the development, production, and distribution of enzymes. Its business consists of two segments, enzyme business and bio business. The Company's enzyme business segment offers detergent enzymes that are used in laundry and dishwashing, technical enzymes used in the transformation of starch into different kinds of sugars and have application in leather, textile, and forest product industries, food enzymes used in production of bread, wine, juice, beer, noodles, alcohol, and pasta and feed enzymes used in animal feed. Its bio business segment offers microorganisms that are used in industrial and municipal wastewater treatment, as well as in the cleaning of surfaces such as carpet, concrete, drain lines, and septic tanks in industrial and household applications. It also has application in the Biopharmaceutical ingredients used in pharmaceutical industry. Novozymes A/S is headquartered in Bagsvaerd, Denmark.

Number of Employees: 6,527

 
 • Price / Volume Information   
Yesterday's Closing Price: $62.86 Daily Weekly Monthly
20 Day Moving Average: 16,499 shares
Shares Outstanding: 227.26 (millions)
Market Capitalization: $14,285.34 (millions)
Beta: 0.57
52 Week High: $83.31
52 Week Low: $57.85
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -4.97% 2.74%
12 Week -3.46% 6.27%
Year To Date -24.37% -9.29%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
Krogshoejvej 36
-
Bagsvaerd,G7 2880
DNK
ph: 45-4446-0000
fax: 45-4446-9999
novozymesir@novozymes.com http://www.novozymes.com
 
 • General Corporate Information   
Officers
Ester Baiget - Chief Executive Officer and President
Jorgen Buhl Rasmussen - Chairman
Cornelis (Cees) de Jong - Vice Chairman
Heine Dalsgaard - Director
Lena Bech Holskov - Director

Peer Information
Novozymes A/S (CSBHY)
Novozymes A/S (ARWM)
Novozymes A/S (FUL)
Novozymes A/S (IAX)
Novozymes A/S (AVD)
Novozymes A/S (ASH)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: CHEM-SPECIALTY
Sector: Basic Materials
CUSIP: 670108109
SIC: 2836
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 06/01/21
Next Expected EPS Date: 05/24/22
Share - Related Items
Shares Outstanding: 227.26
Most Recent Split Date: 12.00 (5.00:1)
Beta: 0.57
Market Capitalization: $14,285.34 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.87%
Current Fiscal Quarter EPS Consensus Estimate: $0.37 Indicated Annual Dividend: $0.55
Current Fiscal Year EPS Consensus Estimate: $1.66 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: 4.54% Last Dividend Paid: 03/17/2022 - $0.55
Next EPS Report Date: 05/24/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 37.75
Trailing 12 Months: 36.13
PEG Ratio: 8.32
Price Ratios
Price/Book: 7.39
Price/Cash Flow: 28.67
Price / Sales: 6.01
EPS Growth
vs. Year Ago Period: 35.29%
vs. Previous Quarter: -9.80%
Sales Growth
vs. Year Ago Period: 6.82%
vs. Previous Quarter: -1.12%
ROE
03/31/22 - -
12/31/21 - 27.43
09/30/21 - 28.86
ROA
03/31/22 - -
12/31/21 - 13.88
09/30/21 - 14.99
Current Ratio
03/31/22 - -
12/31/21 - 1.38
09/30/21 - 1.63
Quick Ratio
03/31/22 - -
12/31/21 - 0.85
09/30/21 - 0.98
Operating Margin
03/31/22 - -
12/31/21 - 21.03
09/30/21 - 21.81
Net Margin
03/31/22 - -
12/31/21 - 21.04
09/30/21 - 21.81
Pre-Tax Margin
03/31/22 - -
12/31/21 - 26.25
09/30/21 - 27.24
Book Value
03/31/22 - -
12/31/21 - 8.51
09/30/21 - 8.04
Inventory Turnover
03/31/22 - -
12/31/21 - 2.28
09/30/21 - 2.41
Debt-to-Equity
03/31/22 - -
12/31/21 - 0.30
09/30/21 - 0.32
Debt-to-Capital
03/31/22 - -
12/31/21 - 23.17
09/30/21 - 24.28
 

Powered by Zacks Investment Research ©